Effects of finasteride on vascular endothelial growth factor.
about
Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeksEffects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate.Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trialsA systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.Should Finasteride Be Routinely Given Preoperatively for TURP?Effect of dutasteride on the expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in rat and human prostate tissue.Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shockVascular endothelial growth factor in serum indicates cardiovascular risk in urology patients.Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride.Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination.Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.
P2860
Q28193374-BC84F2CF-B4F9-47DA-A36A-B7296DEB9410Q35013421-CC09151C-2C7B-4E41-8298-04D60ED10EB9Q35649097-5832E6CE-C109-4EA9-B66D-3C329897B9E7Q37926474-2E9A635D-49EA-40D3-A084-9F895955AF0DQ38132179-100B2E4F-5722-4DC2-9F30-10B790E40FB6Q38490532-3CA16E1D-91A5-4E21-8EE1-2AADF10FCF79Q38943194-039CF10D-503D-4926-BD00-F81AFDE0943AQ41786181-36479AC2-CBB2-4AC7-85BE-8F9FBDD481D2Q45054620-B4D98B56-2526-4301-B3CD-37EFB3A2C45FQ47809352-5D836658-0C89-4460-9855-F7231B3EE2F9Q48608872-A081DD93-21CE-44EF-98D1-26BB26DE856AQ52407108-5AEA5C72-31FA-4FBD-8247-4DA3A353506FQ54375534-9A305727-7A42-4668-B8F4-6E983326D1E3
P2860
Effects of finasteride on vascular endothelial growth factor.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of finasteride on vascular endothelial growth factor.
@en
Effects of finasteride on vascular endothelial growth factor.
@nl
type
label
Effects of finasteride on vascular endothelial growth factor.
@en
Effects of finasteride on vascular endothelial growth factor.
@nl
prefLabel
Effects of finasteride on vascular endothelial growth factor.
@en
Effects of finasteride on vascular endothelial growth factor.
@nl
P2093
P2860
P1476
Effects of finasteride on vascular endothelial growth factor.
@en
P2093
Häggström S
Nielsen JE
P2860
P304
P356
10.1080/003655902320131848
P577
2002-01-01T00:00:00Z